Clin2
NCT07701928Possibly a fitNot yet recruiting

Daridorexant for sleep and alcohol use disorder

Alcohol Use DisorderInsomnia

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial tests if the sleep medication daridorexant can help people who have both insomnia and alcohol use disorder. It looks at whether the drug improves sleep and reduces drinking.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
205 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have insomnia (trouble falling asleep or staying asleep) for at least 3 months, happening 3 or more nights a week.
  • You have an alcohol use disorder (a pattern of drinking that causes problems).
  • You have had 4 or more drinks at least 4 times in the last month.
  • You are at least 18 years old and can read and speak English.
  • You are not currently taking any other sleep or alcohol use disorder medication.
  • You are not at risk for dangerous alcohol withdrawal (no detox or seizure in the last year).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07532252Not yet recruiting· Phase 2
Daridorexant for Alcohol Use Disorder and Sleep Problems

This study tests whether a medication called daridorexant can help people with alcohol use disorder who also have trouble sleeping. The drug works by helping you fall asleep and stay asleep, which may reduce cravings to drink.

NCT07555743Not yet recruiting· Phase 4
New Insomnia Treatment for Depression Patients

This study tests whether a new sleep medication called daridorexant helps people with depression who also struggle with insomnia. You would take this medication for several weeks while researchers track how it affects your sleep and mood.

Barcelona, Catalonia
NCT07328594Not yet recruiting· Phase 4
Sleep medication to help smokers quit or cut back

This study tests whether a new sleep medication, daridorexant, can help smokers sleep better and feel more alert during the day, while also supporting their efforts to quit or reduce smoking. You will monitor your sleep at home, keep a diary, and take short mobile tests for 3 weeks.

Portland, Oregon
NCT06326684Recruiting· Early Phase 1
Testing suvorexant for alcohol use disorder

This study tests whether the sleep medication suvorexant can help people with alcohol use disorder drink less. It involves a short stay where you'll receive either suvorexant or a placebo and then have alcohol.

Lexington, Kentucky
NCT07214207Recruiting· Phase 2
Testing a sleep medicine for alcohol use disorder and stress-related drinking

This trial tests whether a medicine called suvorexant, which is used for sleep, can help people with alcohol use disorder drink less, especially when stressed. You would receive the medicine or a placebo, and researchers will track your drinking and stress levels over several weeks.

Columbus, Ohio
NCT06679062Recruiting· Phase 2
Suvorexant for alcohol use disorder and PTSD

This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.

Los Angeles, California

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.